Endece

About Endece

ENDECE, LLC (ENDECE), founded in 2006, is a privately held biopharmaceutical drug discovery and development company with offices in Mequon, Wisconsin and San Francisco, California. The company focuses on small-molecule compounds that control key genes within specific signaling pathways as a platform for discovering drugs capable of treating diseases for which there are no cures. ENDECE’s scientists have created a proprietary library of compounds having the potential to treat diseases such as multiple sclerosis (MS) and Alzheimer’s disease.
YEAR FOUNDED:
2006
LEADERSHIP:
CEO: James Yarger
CAO: Jean Yarger
CLINICAL TRIAL:
Please click here for clinical trial information.
PRODUCTS:
NDC-1308